DLB
Dolby Laboratories
58.00$
-0.6%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -90.1% | +2,057.3% | -88.3% | +446.3% | -8.1% | +63.8% | -61.3% | +81.5% | -55.4% | +68.8% | +81.0% | – | |
| – | -13.6% | -0.9% | +2.1% | +15.0% | +3.3% | -3.1% | -0.1% | +0.7% | +9.1% | +0.1% | -6.6% | – | |
| – | +13.1% | -9.3% | +1.5% | +1.2% | +21.5% | -15.0% | +0.2% | +1.1% | +19.8% | -17.5% | +0.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2,026.4% | – | -245.8% | – | -210.5% | – | -175.9% | – | – | – | – | – | |
| – | -25.5% | +46.2% | -14.6% | -3.1% | -8.1% | +1.7% | -6.8% | +239.7% | -75.4% | +757.0% | -57.1% | – | |
| – | – | -2,923.5% | -56.7% | +3,274.3% | -96.9% | – | -124.8% | +240.9% | – | -3,801.8% | -78.8% | – | |
| – | +10.6% | +0.6% | 0.0% | -0.3% | +10.3% | +0.9% | -0.6% | -0.1% | +8.7% | 0.0% | -1.0% | – | |
| – | +316.2% | -76.9% | +37.3% | -40.5% | +119.1% | -23.0% | +12.8% | -10.0% | +172.9% | -35.8% | +1.4% | – | |
| – | +192.4% | -64.7% | +32.2% | +3.0% | -4.2% | +12.7% | -6.4% | +5.5% | +90.2% | -18.0% | -8.9% | – | |
| – | -681.2% | – | -139.5% | – | – | +309.0% | -95.5% | +491.4% | -278.8% | – | – | – | |
| – | -97.0% | +7,367.2% | -92.1% | +696.9% | -8.1% | +68.0% | -63.5% | +64.9% | -51.1% | -6.1% | +218.1% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.